Clinical trial • Phase I • Other
Clinical trial in Urinary incontinence
Phase I trial for Urinary incontinence. open-label. 15 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Urinary incontinence
- Trial Stage
- Phase I
- Drug Modality
- Cell therapy
Key dates
- Initial CTIS Submission Date
- 25-07-2024
- First CTIS Authorization Date
- 31-10-2024
Trial design
open-label Phase I trial across 2 sites in Poland.
- Open Label
- Yes
- Target Sample Size
- 15
Eligibility
Recruits 15 No vulnerable populations selected; no specific consent or assent handling described..
- Vulnerable Population
- No vulnerable populations selected; no specific consent or assent handling described.
Recruitment
- Planned Sample Size
- 15
- Recruitment Window Months
- 17
Geography
- Total Number Of Sites
- 2
- Total Number Of Participants
- 15
Poland
- Earliest CTIS Part Ii Submission Date
- 01-10-2024
- Latest Decision Or Authorization Date
- 15-04-2026
- Processing Time Days
- 562
- Number Of Sites
- 2
- Number Of Participants
- 15
Sites
- Site Name
- Nicolaus Copernicus Hospital
- Department Name
- Oddział urologii ogólnej i onkologicznej
- Principal Investigator Name
- Przemysław Adamczyk
- Principal Investigator Email
- urologia@med.torun.pl
- Contact Person Name
- Przemysław Adamczyk
- Contact Person Email
- urologia@med.torun.pl
- Site Name
- Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy
- Department Name
- Klinika Urologii Ogólnej i Onkologicznej
- Principal Investigator Name
- Tomasz Drewa
- Principal Investigator Email
- t.drewa@wp.pl
- Contact Person Name
- Tomasz Drewa
- Contact Person Email
- t.drewa@wp.pl
Sponsor
Primary sponsor
- Full Name
- Nicolaus Copernicus University
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Poland
Related trials
Other published trials that may interest you.